1. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer resistant murine tumor cells by lymphocytes cultured in interleukin-2;Rosenstein;Cancer Res.,1984
2. The human lymphokine-activated killer cell phenomenon;Grimm,1983
3. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts;LeFor;J. Immunol.,1988
4. The potential usefulness of IL-2 activated bone marrow as an active therapeutical approach against CMV infection in the bone marrow transplantation setting;Agar;J. Clin. Immunol.,1989
5. Human T cell clones use a CD3 associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity;David;J. Immunol.,1987